1Suppliers
4Customers
1Debt Items
0Related Chains

Senti Biosciences Holdings, Inc. Suppliers

TickerNameConfidenceEvidence
CELADON-PARTNERS-SPV-24 CELADON-PARTNERS-SPV-24 92% The Investor is an entity affiliated with Celadon Partners SPV 24

Senti Biosciences Holdings, Inc. Customers

TickerNameConfidenceEvidence
GENEFAB GENEFAB 92% The Letter Agreement provides, among other things, that the outstanding base rent of $1,374,005 owed by GeneFab to the Company may be satisfied, in whole or in part, through a cash prepayment credit …
BLUEROCK-THERAPEUTICS-LP BLUEROCK-THERAPEUTICS-LP 90% In May 2021, we entered into a Collaboration and Option Agreement with BlueRock Therapeutics LP.
CELEST-THERAPEUTICS CELEST-THERAPEUTICS 90% If Celest Therapeutics exercises its option during the option exercise period, the parties shall negotiate the terms of the license agreement, which will include and be consistent with pre-agreed fin…
SPARK-THERAPEUTICS SPARK-THERAPEUTICS 85% Pursuant to the Spark Agreement, we received an upfront payment from Spark Therapeutics of $3 million.

Senti Biosciences Holdings, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SNTI-DEBT-12651 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-12-31.

Senti Biosciences Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Senti Biosciences Holdings, Inc..

Senti Biosciences Holdings, Inc. Ownership

HolderNameConfidenceEvidence
SNTI-OWNER-NEA-MANAGEMENT-COMPANY-LLC NEA Management Company, LLC 90% 13F overlay lists NEA Management Company, LLC as top holder; 16 tracked holders.

Senti Biosciences Holdings, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.